Lessons from metabolic perturbations in lysosomal storage disorders for neurodegeneration

被引:7
|
作者
Medoh, Uche N. [1 ,2 ,3 ,4 ]
Chen, Julie Y. [1 ,2 ,3 ]
Abu-Remaileh, Monther [1 ,2 ,3 ]
机构
[1] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[3] Stanford Univ, Inst Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
Lysosomal storage disorders; Neurodegeneration; Metabolism; Parkinson?s disease; Alzheimer?s disease; Lipid metabolism; Calcium dyshomeostasis; Mitochondrial dysfunction; Oxidative stress; Autophagy; NIEMANN-PICK-DISEASE; OXIDATIVE STRESS; C-DISEASE; AUTOPHAGY; ACCUMULATION; HOMEOSTASIS; GLUCOCEREBROSIDASE; GLUCOSYLCERAMIDE; PARKINSONISM; MITOCHONDRIA;
D O I
10.1016/j.coisb.2021.100408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Age-related neurodegenerative diseases are a clinically unmet need with unabated prevalence around the world. Several genetic studies link these diseases with lysosomal dysfunction; however, a mechanistic understanding of how lysosomal per-turbations result in neurodegeneration is unclear. Neuro-nopathic lysosomal storage disorders represent an attractive model for elucidating such mechanisms as they share several metabolic pathological hallmarks with common neurodegen-erative diseases. This review explores how altered lipid metabolism, calcium dyshomeostasis, mitochondrial dysfunc-tion, oxidative stress, and impaired autophagic flux contribute to cellular pathobiology in age-related neurodegeneration and neuronopathic lysosomal storage disorders. It further debates whether general lysosomal dysfunction owing to toxic sub-strate accumulation or extralysosomal nutrient deprivation drives these downstream processes. With increasing evidence for the latter, future studies should investigate additional lyso-somal nutrients that protect against neurodegeneration using emerging subcellular ???omics???-based technologies with the promise of identifying therapeutic targets for the treatment of neurodegenerative diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Autophagy in lysosomal storage disorders
    Lieberman, Andrew P.
    Puertollano, Rosa
    Raben, Nina
    Slaugenhaupt, Susan
    Walkley, Steven U.
    Ballabio, Andrea
    AUTOPHAGY, 2012, 8 (05) : 719 - 730
  • [22] Sphingolipid lysosomal storage disorders
    Platt, Frances M.
    NATURE, 2014, 510 (7503) : 68 - 75
  • [23] Radiology of Lysosomal Storage Disorders
    Kanekar, S.
    Pennypacker, J.
    Chetlen, A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [24] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [25] Targeting protein aggregation in neurodegeneration - lessons from polyglutamine disorders
    Weydt, Patrick
    La Spada, Albert R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 505 - 513
  • [26] DIAGNOSIS OF LYSOSOMAL STORAGE DISORDERS
    KERR, C
    MEDICAL JOURNAL OF AUSTRALIA, 1984, 140 (04) : 188 - 189
  • [27] Lysosomal Storage Disorders and Iron
    Bras, Jose Miguel
    METAL RELATED NEURODEGENERATIVE DISEASE, 2013, 110 : 251 - 275
  • [28] Treatment for Lysosomal Storage Disorders
    Sheth, Jayesh
    Nair, Aadhira
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (40) : 5110 - 5118
  • [29] Prevalence of lysosomal storage disorders
    Meikle, PJ
    Hopwood, JJ
    Clague, AE
    Carey, WF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03): : 249 - 254
  • [30] Sphingolipid lysosomal storage disorders
    Frances M. Platt
    Nature, 2014, 510 : 68 - 75